These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1380620)

  • 1. Vasoactive peptides and growth factors in the pathophysiology of hypertension.
    Scott-Burden T; Hahn AW; Bühler FR; Resink TJ
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S55-64. PubMed ID: 1380620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of peptide vasoconstrictors on vessel structure.
    Hahn AW; Resink TJ; Mackie E; Scott-Burden T; Bühler FR
    Am J Med; 1993 Apr; 94(4A):13S-19S. PubMed ID: 8488851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets, growth factors, and vascular smooth-muscle cells in hypertension and diabetes.
    Mikhail N; Fukuda N; Tremblay J; Hamet P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S64-74. PubMed ID: 7508064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renin-angiotensin system and extracellular matrix.
    Hahn AW; Kern F; Bühler FR; Resink TJ
    Clin Investig; 1993; 71(5 Suppl):S7-12. PubMed ID: 8518542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of endothelin secretion by angiotensin II: effects on growth and synthetic activity of vascular smooth muscle cells.
    Scott-Burden T; Resink TJ; Hahn AW; Vanhoutte PM
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S96-100. PubMed ID: 1725442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative variability of endothelial clones derived from adult bovine aorta: influence of fibroblast growth factor and smooth muscle cell extracellular matrix.
    Longenecker JP; Kilty LA; Ridge JA; Miller DC; Johnson LK
    J Cell Physiol; 1983 Jan; 114(1):7-15. PubMed ID: 6219118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: models of de-endothelialization and repair.
    Madri JA; Bell L; Marx M; Merwin JR; Basson C; Prinz C
    J Cell Biochem; 1991 Feb; 45(2):123-30. PubMed ID: 1711525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of extracellular matrix by angiotensin II: stimulated glycoconjugate synthesis and growth in vascular smooth muscle cells.
    Scott-Burden T; Hahn AW; Resink TJ; Bühler FR
    J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S36-41. PubMed ID: 1705626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance control in hypertension.
    Korner PI; Bobik A; Angus JA; Adams MA; Friberg P
    J Hypertens Suppl; 1989 Sep; 7(4):S125-34; discussion S135. PubMed ID: 2681590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of smooth muscle cell behaviour by platelet-derived factors and the extracellular matrix.
    Wren FE; Schor AM; Schor SL; Grant ME
    J Cell Physiol; 1986 May; 127(2):297-302. PubMed ID: 3700485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of cardiovascular hypertrophy: the role of the renin-angiotensin system.
    Paul M; Ganten D
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S51-8. PubMed ID: 1381795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced growth and growth factor responsiveness of vascular smooth muscle cells from hypertensive rats.
    Scott-Burden T; Resink TJ; Bühler FR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 6():S16-21. PubMed ID: 2478819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factors and vascular smooth muscle cell growth responses.
    Delafontaine P
    Eur Heart J; 1998 Jul; 19 Suppl G():G18-22. PubMed ID: 9717051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blunted attenuation of angiotensin II-mediated Ca2+ transients by insulin in cultured unpassaged vascular smooth muscle cells from spontaneously hypertensive rats.
    Touyz RM; Tolloczko B; Schiffrin EL
    Am J Hypertens; 1995 Feb; 8(2):104-12. PubMed ID: 7755938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients.
    Schiffrin EL; Deng LY; Larochelle P
    Clin Invest Med; 1993 Jun; 16(3):177-86. PubMed ID: 8365045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular structure, smooth muscle cell phenotype and growth in hypertension.
    Lindop GB; Boyle JJ; McEwan P; Kenyon CJ
    J Hum Hypertens; 1995 Jun; 9(6):475-8. PubMed ID: 7473530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of vascular hypertrophy in hypertension].
    Tedgui A
    Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():67-72. PubMed ID: 8215782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pericyte growth and contractile phenotype: modulation by endothelial-synthesized matrix and comparison with aortic smooth muscle.
    Newcomb PM; Herman IM
    J Cell Physiol; 1993 May; 155(2):385-93. PubMed ID: 8482730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New aspects of vascular remodelling: the involvement of all vascular cell types.
    McGrath JC; Deighan C; Briones AM; Shafaroudi MM; McBride M; Adler J; Arribas SM; Vila E; Daly CJ
    Exp Physiol; 2005 Jul; 90(4):469-75. PubMed ID: 15894533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium dysfunction in the coronary circulation.
    Lüscher TF; Noll G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S16-26. PubMed ID: 7700060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.